NCT05919173View on ClinicalTrials.gov

Comparison Between Bupivacaine and Bupivacaine With Dexmedetomidine in Caudal Block for Post Operative Pain Control

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 10, 2021

Primary Completion Date

November 15, 2021

Study Completion Date

November 20, 2021

Conditions
Post Operative Pain
Interventions
DRUG

Bupivacaine Hydrochloride 0.25% Injection Solution

Bupivacaine Hydrochloride 0.25% Injection Dose: 1mL/kg (milliliter per kilogram body weight)

DRUG

Bupivacaine Hydrochloride 0.25% Injection plus Dexmedetomidine 1 microgram/kg body weight

Bupivacaine HCL 0.25% Injection plus Dexmedetomidine 1micro/kg Dose: 1 mL/kg (milliliter per kilogram body weight)

Trial Locations (1)

74200

Sindh Institute of Urology and Transplantation. Department of Anaesthesia and Surgical Intensive Care Units, Karachi

All Listed Sponsors
lead

Sindh Institute of Urology and Transplantation

OTHER